<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:xhtml="http://www.w3.org/1999/xhtml">
    <url>
        <loc>https://www.maxiontherapeutics.com</loc>
    </url>
    <url>
        <loc>https://www.maxiontherapeutics.com/terms-conditions</loc>
    </url>
    <url>
        <loc>https://www.maxiontherapeutics.com/careers</loc>
    </url>
    <url>
        <loc>https://www.maxiontherapeutics.com/news</loc>
    </url>
    <url>
        <loc>https://www.maxiontherapeutics.com/news-old/maxion-therapeutics-strengthens-its-board-with-the-appointment-of-ian-tomlinson-chairman-tom-weaver-non-executive-director-and-aneesh-karatt-vellatt-director</loc>
    </url>
    <url>
        <loc>https://www.maxiontherapeutics.com/current-vacancies/protein-scientist-membrane-protein</loc>
    </url>
    <url>
        <loc>https://www.maxiontherapeutics.com/current-vacancies/scientist-senior-scientist-therapeutic-antibody-discovery-and-engineering</loc>
    </url>
    <url>
        <loc>https://www.maxiontherapeutics.com/news/ion-channel-drug-developer-maxion-therapeutics-appoints-eva-lotta-allan-as-chair-of-its-board-of-directors</loc>
    </url>
    <url>
        <loc>https://www.maxiontherapeutics.com/news/lilly-backed-uk-biotech-raises-72m-to-advance-its-antibody-approach</loc>
    </url>
    <url>
        <loc>https://www.maxiontherapeutics.com/news/maxion-raises-72m-in-series-a-advancing-max001</loc>
    </url>
    <url>
        <loc>https://www.maxiontherapeutics.com/news/maxion-therapeutics-16-million-series-a-to-drive-antibody-development-for-previously-untreatable-ion-channel-and-gpcr-driven-diseases</loc>
    </url>
    <url>
        <loc>https://www.maxiontherapeutics.com/news/maxion-therapeutics-appoints-joel-edwards-cbo</loc>
    </url>
    <url>
        <loc>https://www.maxiontherapeutics.com/news/maxion-therapeutics-awarded-2-million-innovate-uk-funding-to-develop-ion-channel-antibodies-for-hard-to-treat-autoimmune-diseases</loc>
    </url>
    <url>
        <loc>https://www.maxiontherapeutics.com/news/maxion-therapeutics-breakthrough-science-and-innovation-recognised-in-pwc-uks-life-sciences-future50-list</loc>
    </url>
    <url>
        <loc>https://www.maxiontherapeutics.com/news/maxion-therapeutics-doubles-r-d-space-at-unity-campus-after-58-million-series-a-fundraise</loc>
    </url>
    <url>
        <loc>https://www.maxiontherapeutics.com/news/maxion-therapeutics-expands-team-and-facilities-with-move-to-unity-campus</loc>
    </url>
    <url>
        <loc>https://www.maxiontherapeutics.com/news/maxion-therapeutics-highly-commended-in-employer-of-the-year-category-at-cambridge-independent-science-and-technology-awards</loc>
    </url>
    <url>
        <loc>https://www.maxiontherapeutics.com/news/maxion-therapeutics-raises-72-million-in-an-oversubscribed-series-a-financing-to-advance-its-knotbody-r-pipeline-and-platform</loc>
    </url>
    <url>
        <loc>https://www.maxiontherapeutics.com/news/maxion-therapeutics-strengthens-its-board-with-the-appointment-of-ian-tomlinson-chairman-tom-weaver-non-executive-director-and-aneesh-karatt-vellatt-director</loc>
    </url>
    <url>
        <loc>https://www.maxiontherapeutics.com/news/maxion-therapeutics-welcomes-dr-arndt-schottelius-as-new-ceo</loc>
    </url>
    <url>
        <loc>https://www.maxiontherapeutics.com/news/maxion-therapeutics-wins-start-up-of-the-year-at-2023-cambridge-independent-science-technology-awards</loc>
    </url>
    <url>
        <loc>https://www.maxiontherapeutics.com/news/rising-leaders-2025-aneesh-karatt-vellatt-on-maxion-therapeutics-antibody-revolution</loc>
    </url>
</urlset>